EditCo Bio and Telegraph Hill Partners Acquire Synthego’s Engineered Cell Solutions Business to Enable Cellular Research

EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego’s engineered cell solutions and enhanced guide RNA business. Borne from Synthego’s cell engineering expertise, EditCo is uniquely positioned to deliver edited cells and highly optimized guide RNA designs for the rapidly expanding CRISPR market. EditCo will operate as an independent business with financing and support from life sciences investment firm Telegraph Hill Partners. EditCo will offer researchers simple one-click access to high-quality engineered cells with guaranteed edits in their desired targets, minimizing time and effort spent in experiments. By ushering in unprecedented predictability in biology, EditCo lays the foundation for rapid outcomes in basic biology and cell and gene therapy research.

Read the full article: EditCo Bio and Telegraph Hill Partners Acquire Synthego’s Engineered Cell Solutions Business to Enable Cellular Research //

Source: https://www.prnewswire.com/news-releases/editco-bio-and-telegraph-hill-partners-acquire-synthegos-engineered-cell-solutions-business-to-enable-cellular-research-302100055.html

Leave a Comment

Your email address will not be published.

Scroll to Top